(Q36945945)

17 August 2017

title

Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review (English)

1 reference

17 August 2017

0 references

0 references

surgical intervention

1 reference

E H Kraut

1

1 reference

17 August 2017

L M Aledort

2

1 reference

17 August 2017

S Arkin

3

1 reference

17 August 2017

K C Stine

4

1 reference

17 August 2017

W-Y Wong

5

1 reference

17 August 2017

publication date

1 September 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

13

1 reference

17 August 2017

issue

5

1 reference

17 August 2017

page(s)

508-517

1 reference

Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Literature review of surgery management in inhibitor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Elective orthopedic surgery for hemophilia patients with inhibitors: New opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Options for treating acute bleeds in addition to bypassing agents: extracorporeal immunoadsorption, FVIII/FIX, desmopressin and antifibrinolytics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Orthopaedic surgery in haemophilic patients with inhibitors: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Surgery in haemophilic patients with inhibitor: 20 years of experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Case studies: orthopaedic surgery in adult patients with haemophilia A with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Haemophilia and thrombophilia: an unexpected association!

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Venous thromboembolism after hip fracture surgery in a patient with haemophilia B and factor V Arg506Gln (factor V Leiden).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

The use of recombinant factor VIIa in the treatment of bleeding disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Identifying and managing inhibitor patients requiring orthopaedic surgery - the multidisciplinary team approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Acquired factor VIII inhibitors: pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Monitoring the bioavailability of FEIBA with a thrombin generation assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01523.X

10.1111/J.1365-2516.2007.01523.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference